Results 111 to 120 of about 3,412 (160)

Psychedelic studies in nonhuman primates: Past and future. [PDF]

Mol Psychiatry
Masthay JC, Kwan AC, Chang SWC.
europepmc   +1 more source

Novel Tricyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches. [PDF]

ACS Med Chem Lett
Sabnis RW, Sabnis AR.
europepmc   +1 more source

Novel Indoline Derivatives Serotonergic Psychedelic Agents as 5‑HT2A Agonists for Treating Psychosis, Mental Illness and CNS Disorders. [PDF]

ACS Med Chem Lett
Sabnis RW, Sabnis AR.
europepmc   +1 more source

Determination and Confirmation of Psychedelic and Psychoactive Compounds in Botanical Materials by UPLC-ESI-MS/MS: Single-Laboratory Validation. [PDF]

J AOAC Int
French T, Fontana AJ, LaBudde R, Brunelle SL, Sudberg S.   +4 more
europepmc   +1 more source

Psychedelic-Assisted Interventions in Palliative Care: A Narrative Overview and Critical Evaluation. [PDF]

Healthcare (Basel)
Soares DA, Campolina AG.
europepmc   +1 more source

Keeping an Open Mind About (and With) Psychedelics. [PDF]

Biol Psychiatry
Novick AM, Ross DA.
europepmc   +1 more source

The renaissance of research on psychedelics in child and adolescent psychopharmacology. [PDF]

Child Adolesc Psychiatry Ment Health
Crocq MA, Auby P.
europepmc   +1 more source

Psychedelic Drugs Rediscovered-In Silico Study of Potential Fetal Exposure to Analogues of Psychedelic Drugs During Pregnancy. [PDF]

Molecules
Sobańska AW, Sobański AM, Brzezińska E.   +2 more
europepmc   +1 more source

Sex-dependent effects of psychedelics: review of evidence from rodent models. [PDF]

Front Psychiatry
Marecki R, Zaniewska W, Hamed A, Waszkiewicz N, Baker JJ, Łukasiewicz K.   +5 more
europepmc   +1 more source